Pharmaceuticals, Biotechnology and Life Sciences
RAPID, the only clinically validated, next-generation imaging platform for assessing ischemic stroke, now available in Japan MENLO PARK, Calif.–(BUSINESS WIRE)–#AI–iSchemaView,…
BRUSSELS–(BUSINESS WIRE)–Eurofins Consumer Products Testing (CPT) is proud to announce the acquisition of LAB Solution S.r.l. The acquisition is a…
ObsEva has completed recruiting patients for its Phase 3 clinical trial PRIMROSE 1 testing of oral gonadotropin releasing hormone (GnRH) receptor antagonist linzagolix for the treatment of heavy menstrual bleeding (HMB) associated with uterine fibroids (UF).
4D pharma has started with a multicentre Phase I/II double-blind, placebo-controlled study of MRx-4DP0004 in patients with poorly controlled asthma.
OneOncology and AmerisourceBergen to Support Community Oncology Practices to Provide High-Quality Cancer Care to Patients Across the Nation VALLEY FORGE,…
SQ Innovation will use Ligand’s Captisol technology to achieve a smaller delivery volume for more cost-effective diuretic treatment in heart…
Lannett Company has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Cediprof, Inc., a wholly owned subsidiary of privately held Neolpharma Pharmaceutical Group.
Astrazeneca has entered partnership with the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) named the Lung Ambition Alliance, to try to eliminate lung cancer as a cause of death.
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Compass Therapeutics, a clinical-stage biotechnology company targeting the human immune synapse with a new generation of monoclonal and…